add share buttonsSoftshare button powered by web designing, website development company in India

Everything You Need To Know About The Zantac Recall

Zantac, a brand-name form of ranitidine that is an H2 antagonist, is used to treat heartburn and ulcers. It has been used as an over-the-counter medicine for many years to provide relief from common health conditions. Recently, Zantac was recalled due to traces of NDMA in the drug. We strongly recommend that you speak to an attorney if you have taken Zantac or been diagnosed with cancer.

Contact your doctor immediately if you have Zantac cancer symptoms. If you have suffered any of these types from cancer after taking Zantac, or any combination of brand-name and generic drugs you can file Zantac tumor legal action claims against the manufacturer.

Zantac Lawsuit, Zantac Lawyers

Image Source: Google

Zantac Products Removed From The Market:

Recent studies have linked Zantac and other ranitidine-containing drugs to cancer. The Food and Drug Administration (FDA), recently ordered that all Zantac and ranitidine products be removed from the market. Several major drugstore chains had stopped selling the drugs last year. One chain offered refunds for purchases made in the past. These extraordinary measures were prompted by the FDA's detection that NDMA, a known carcinogen, was in Zantac as well as other ranitidine products.

NDMA – Dangerous Contaminant Detected at Zantac:

N-Nitrosodimethylamine, or NDMA, is a contaminant that both the World Health Organization (WHO) and the International Agency of Research on Cancer (IARC) identify as a probable carcinogen. High doses of NDMA are closely linked to colorectal cancer and other types of cancer. NDMA can also cause liver damage, even in very small amounts.

The following cancers could possibly be caused by Zantac

  • Colorectal
  • Kidney
  • Intestinal
  • Esophageal
  • Liver
  • Stomach
  • Pancreatic
  • Ovarian
  • Uterine
  • Brain
  • Throat/nasal
  • Breast
  • Thyroid
  • Testicular
  • Prostate
  • Leukemia
  • Bladder
  • Lung
  • Multiple myeloma
  • Non-Hodgkins lymphoma